Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Share your tracking data with your healthcare provider at each visit, either through patient portal uploads, printed summaries, or app-generated reports
doi: 10.1007/s00125-017-4447-4 7 GokeRFehmannHCLinnTSchmidtHKrauseMEngJet al
Epidemiologic studies have consistently shown a mortality advantage among patients with hematocrits in the 30% to 36% range, and the NKF-DOQI Work Group on Anemia Management recommended a target hematocrit of 33% to 36% based on the expert panels' detailed literature review
Speaking at a recent National Academies of Sciences, Engineering and Medicine webinar, Ard said knowing how to slowly titrate the dosage of GLP-1 drugs and knowing when to switch to a different medication can help patients stay the course
US$ 23.85
US$ 25.41
US$ 28.90
US$ 28.55
US$ 27.30
US$ 29.47
